This announcement is a separate document:
易瑞生物：东兴证券股份有限公司关于深圳市易瑞生物技术股份有限公司向不特定对象发行可转换公司债券2024年度第一次临时受托管理事务报告
Yirui Biology: Dongxing Securities Co., Ltd.\'s first temporary fiduciary management report on the issuance of convertible corporate bonds by Shenzhen Yirui Biotechnology Co., Ltd. to unspecified targets in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated